News
Sunflower Therapeutics announces the first system delivery and installation of its Daisy Petal™ to the BioBuilder Education Foundation.
MEDFORD, Mass., May 19, 2025--Sunflower Therapeutics announces the first system delivery and installation of its Daisy Petal™ to the BioBuilder Education Foundation.
MEDFORD, Mass., May 19, 2025--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, ...
The first delivery and installation of the Daisy Petal™ to BioBuilder’s Learning Lab Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein ...
Researchers have developed a hollow fiber bioreactor that mimics a circulatory system, overcoming challenges in tissue thickness and nutrient delivery. This breakthrough enables the scalable ...
Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today its first distribution ...
Through this agreement, Sunflower will commercially launch its Daisy Petal™ Perfusion Bioreactor System in Asia, a significant step in the company’s ongoing product commercialization.
MEDFORD, Mass., February 26, 2025--Sunflower Therapeutics announced its first distribution agreement with PharmNXT Biotech to launch its Daisy Petal Perfusion Bioreactor System in Asia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results